These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
163 related articles for article (PubMed ID: 17616114)
1. Synthesis and biological activity of azido analogues of 5,6-dimethylxanthenone-4-acetic acid for use in photoaffinity labeling. Palmer BD; Henare K; Woon ST; Sutherland R; Reddy C; Wang LC; Kieda C; Ching LM J Med Chem; 2007 Aug; 50(16):3757-64. PubMed ID: 17616114 [TBL] [Abstract][Full Text] [Related]
2. Induction of intratumoral tumor necrosis factor (TNF) synthesis and hemorrhagic necrosis by 5,6-dimethylxanthenone-4-acetic acid (DMXAA) in TNF knockout mice. Ching LM; Goldsmith D; Joseph WR; Körner H; Sedgwick JD; Baguley BC Cancer Res; 1999 Jul; 59(14):3304-7. PubMed ID: 10416582 [TBL] [Abstract][Full Text] [Related]
3. Stimulation of tumors to synthesize tumor necrosis factor-alpha in situ using 5,6-dimethylxanthenone-4-acetic acid: a novel approach to cancer therapy. Joseph WR; Cao Z; Mountjoy KG; Marshall ES; Baguley BC; Ching LM Cancer Res; 1999 Feb; 59(3):633-8. PubMed ID: 9973211 [TBL] [Abstract][Full Text] [Related]
4. Labeling of oxidizable proteins with a photoactivatable analog of the antitumor agent DMXAA: evidence for redox signaling in its mode of action. Brauer R; Wang LC; Woon ST; Bridewell DJ; Henare K; Malinger D; Palmer BD; Vogel SN; Kieda C; Tijono SM; Ching LM Neoplasia; 2010 Sep; 12(9):755-65. PubMed ID: 20824052 [TBL] [Abstract][Full Text] [Related]
5. Immune-modulating and anti-vascular activities of two xanthenone acetic acid analogues: A comparative study to DMXAA. Barbera M; Kettunen MI; Caputo A; Hu DE; Gobbi S; Brindle KM; Carrara M Int J Oncol; 2009 Jan; 34(1):273-9. PubMed ID: 19082498 [TBL] [Abstract][Full Text] [Related]
6. Increased plasma serotonin following treatment with flavone-8-acetic acid, 5,6-dimethylxanthenone-4-acetic acid, vinblastine, and colchicine: relation to vascular effects. Baguley BC; Zhuang L; Kestell P Oncol Res; 1997; 9(2):55-60. PubMed ID: 9167186 [TBL] [Abstract][Full Text] [Related]
7. Synthesis and anti-tubulin activity of a 3'-(4-azidophenyl)-3'-dephenylpaclitaxel photoaffinity probe. Spletstoser JT; Flaherty PT; Himes RH; Georg GI J Med Chem; 2004 Dec; 47(26):6459-65. PubMed ID: 15588080 [TBL] [Abstract][Full Text] [Related]
8. Suppression of serum tumour necrosis factor-alpha by thalidomide does not lead to reversal of tumour vascular collapse and anti-tumour activity of 5,6-dimethylxanthenone-4-acetic acid. Browne WL; Wilson WR; Baguley BC; Ching LM Anticancer Res; 1998; 18(6A):4409-13. PubMed ID: 9891501 [TBL] [Abstract][Full Text] [Related]
9. Mechanisms of tumor vascular shutdown induced by 5,6-dimethylxanthenone-4-acetic acid (DMXAA): Increased tumor vascular permeability. Zhao L; Ching LM; Kestell P; Kelland LR; Baguley BC Int J Cancer; 2005 Aug; 116(2):322-6. PubMed ID: 15800918 [TBL] [Abstract][Full Text] [Related]
10. Synthesis, characterization, and biological properties of 8-azido- and 8-amino-substituted 2',5'-oligoadenylates. Sawai H; Hirano A; Mori H; Shinozuka K; Dong B; Silverman RH J Med Chem; 2003 Nov; 46(23):4926-32. PubMed ID: 14584943 [TBL] [Abstract][Full Text] [Related]
11. Induction of tumor necrosis factor-alpha messenger RNA in human and murine cells by the flavone acetic acid analogue 5,6-dimethylxanthenone-4-acetic acid (NSC 640488). Ching LM; Joseph WR; Crosier KE; Baguley BC Cancer Res; 1994 Feb; 54(4):870-2. PubMed ID: 8313372 [TBL] [Abstract][Full Text] [Related]
12. Synthesis and biological evaluation of photoaffinity labeled fusidic acid analogues. Riber D; Venkataramana M; Sanyal S; Duvold T J Med Chem; 2006 Mar; 49(5):1503-5. PubMed ID: 16509567 [TBL] [Abstract][Full Text] [Related]
13. Induction of endothelial cell apoptosis by the antivascular agent 5,6-Dimethylxanthenone-4-acetic acid. Ching LM; Cao Z; Kieda C; Zwain S; Jameson MB; Baguley BC Br J Cancer; 2002 Jun; 86(12):1937-42. PubMed ID: 12085190 [TBL] [Abstract][Full Text] [Related]
14. Novel azido and isothiocyanato analogues of [3-(4-phenylalkylpiperazin-1-yl)propyl]bis(4-fluorophenyl)amines as potential irreversible ligands for the dopamine transporter. Cao J; Lever JR; Kopajtic T; Katz JL; Pham AT; Holmes ML; Justice JB; Newman AH J Med Chem; 2004 Dec; 47(25):6128-36. PubMed ID: 15566284 [TBL] [Abstract][Full Text] [Related]
15. Correlation between immune and vascular activities of xanthenone acetic acid antitumor agents. Zwi LJ; Baguley BC; Gavin JB; Wilson WR Oncol Res; 1994; 6(2):79-85. PubMed ID: 7949468 [TBL] [Abstract][Full Text] [Related]
16. Consequences of increased vascular permeability induced by treatment of mice with 5,6-dimethylxanthenone-4-acetic acid (DMXAA) and thalidomide. Chung F; Liu J; Ching LM; Baguley BC Cancer Chemother Pharmacol; 2008 Mar; 61(3):497-502. PubMed ID: 17473922 [TBL] [Abstract][Full Text] [Related]
18. The effect of 5,6-dimethylxanthenone-4-acetic acid on tumour necrosis factor production by human immune cells. Patel S; Parkin SM; Bibby MC Anticancer Res; 1997; 17(1A):141-50. PubMed ID: 9066644 [TBL] [Abstract][Full Text] [Related]
19. The ability of coumarin-, flavanon- and flavonol-analogues of flavone acetic acid to stimulate human monocytes. Barbera M; Caputo A; Zampiron A; Gobbi S; Rampa A; Bisi A; Carrara M Oncol Rep; 2008 Jan; 19(1):187-96. PubMed ID: 18097594 [TBL] [Abstract][Full Text] [Related]
20. Design, synthesis, and in vitro pharmacology of new radiolabeled gamma-hydroxybutyric acid analogues including photolabile analogues with irreversible binding to the high-affinity gamma-hydroxybutyric acid binding sites. Sabbatini P; Wellendorph P; Høg S; Pedersen MH; Bräuner-Osborne H; Martiny L; Frølund B; Clausen RP J Med Chem; 2010 Sep; 53(17):6506-10. PubMed ID: 20715819 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]